Nadav Eyal, CEO and co-founder of Eybna joins Cannabis & Tech Today Managing Editor Patricia Miller to discuss huge advancements in cannabis research. Eybna has been studying cannabinoids and terpenes for nearly a decade. In that time, the company has made fascinating discoveries about the complexities of the entourage effect, the endocannabinoid system, and their potential to impact global wellness. In this discussion, Eyal shares how he discovered NT-VRL, a terpene formulation with the potential to treat and prevent coronavirus infection. He also reveals his new line of phytochemical formulations designed to target specific health issues, such as insomnia or anxiety. In this science-packed episode, you’ll discover the true potential of cannabis and what it means for the future of medicine.

This week’s episode of Cannabis Tech Talks is brought to you by Enlighten

If you work in the cannabis space, let Enlighten help your company better understand, navigate and reach customers throughout the entire customer journey by getting started at

Leave a Reply